Automated Clinical Chemistry Analyzers

Automated Clinical Chemistry Analyzers Market Outlook

The global automated clinical chemistry analyzers market is projected to reach USD 12.7 billion by 2033, growing at a robust CAGR of 6.8% from 2025 to 2033. This growth is driven by the increasing prevalence of chronic diseases, the rising demand for quick and accurate diagnostic results, and advancements in technology that enhance the efficiency of laboratory operations. Additionally, the growing emphasis on preventive healthcare and the expansion of healthcare infrastructure in emerging markets are contributing to the rising demand for automated clinical chemistry analyzers. The shift towards point-of-care testing and the integration of artificial intelligence in diagnostics also play a pivotal role in propelling market growth.

Growth Factor of the Market

One of the predominant growth factors for the automated clinical chemistry analyzers market is the increasing incidence of chronic diseases, including diabetes, cardiovascular diseases, and liver disorders, which require frequent monitoring and timely diagnosis. Moreover, the rise in the aging population worldwide has accentuated the need for effective and rapid diagnostic tools that can cater to complex health issues, leading to increased demand for automated analyzers in clinical settings. Furthermore, with the growing focus on laboratory efficiency and the reduction of human error in test results, healthcare facilities are increasingly adopting automated systems, which streamline operations and enhance productivity. The technological advancements in analyzer systems, such as the integration of artificial intelligence and machine learning, are also pushing the market forward by offering enhanced capabilities and more precise diagnostic outcomes. Additionally, the ongoing trend towards decentralized healthcare is creating opportunities for portable and semi-automated analyzers, which can be utilized in remote and rural areas to improve access to diagnostic services.

Key Highlights of the Market

• The market is projected to grow at a CAGR of 6.8% from 2025 to 2033.
• North America held the largest share of the market in 2025, driven by advanced healthcare infrastructure.
• Fully automated analyzers are expected to dominate the product type segment due to their efficiency.
• Hospitals are the largest end-users of automated clinical chemistry analyzers, accounting for over 50% of the market share.
• Emerging economies in Asia Pacific are anticipated to witness significant growth in market demand due to expanding healthcare facilities.

By Product Type

Small Benchtop Analyzers:

Small benchtop analyzers are compact devices designed for limited laboratory space, making them ideal for smaller healthcare settings or clinics. These analyzers offer essential testing capabilities and are user-friendly, allowing for easy operation by staff with minimal training. The growing demand for point-of-care testing solutions, particularly in outpatient settings, has driven the adoption of small benchtop analyzers, as they provide quick results while maintaining accuracy. As healthcare facilities aim to enhance patient experience and reduce waiting times, the popularity of these devices continues to rise, contributing to the segment's growth in the overall automated clinical chemistry analyzers market.

Floor-standing Analyzers:

Floor-standing analyzers are larger systems typically used in high-throughput laboratories such as hospitals and diagnostic centers. These analyzers are capable of processing a higher volume of tests compared to smaller benchtop models, making them suitable for facilities that require efficiency and consistency in testing. With advancements in technology, modern floor-standing analyzers incorporate sophisticated features such as automated sample handling and integrated data management systems that enhance operational efficiency. The increasing demand for comprehensive testing and the emphasis on laboratory automation are expected to significantly drive the growth of this segment in the automated clinical chemistry analyzers market.

Portable Analyzers:

Portable analyzers have emerged as a crucial innovation within the clinical chemistry space, allowing for on-site testing in various environments, including emergency services, rural clinics, and field research settings. These devices are designed for easy transportation and typically operate on battery power, which enables healthcare professionals to perform tests outside traditional laboratory settings. The growing trend towards decentralized healthcare is further fueling the demand for portable analyzers, as they provide rapid diagnostic results that can lead to timely clinical decision-making. Consequently, the portable analyzers segment is anticipated to witness significant growth in the coming years, driven by the need for accessible healthcare solutions.

Semi-automated Analyzers:

Semi-automated analyzers bridge the gap between manual testing and fully automated systems, offering a balance of efficiency and operator control. These devices require some manual intervention, yet they streamline various testing processes to reduce the overall time taken for diagnosis. They are particularly advantageous in laboratories with moderate testing volumes, where automated systems may be too costly or unnecessary. As healthcare laboratories seek to optimize workflows while maintaining a level of hands-on quality control, semi-automated analyzers are expected to gain traction, contributing to the growth of this segment in the automated clinical chemistry analyzers market.

Fully Automated Analyzers:

Fully automated analyzers represent the pinnacle of laboratory technology, capable of performing a wide range of tests with minimal human intervention. These systems are designed to handle large sample volumes efficiently and integrate various processes, including sample preparation, analysis, and result reporting. The significant reduction in turnaround time and the enhanced accuracy of results offered by fully automated analyzers make them highly sought after in high-demand clinical environments. As healthcare facilities continue to prioritize operational efficiency and the reduction of diagnostic errors, the fully automated analyzers segment is projected to dominate the market, reflecting the increasing reliance on automation in laboratory settings.

By Application

Hospitals:

Hospitals are the leading application segment for automated clinical chemistry analyzers, driven by the need for high-volume testing in critical care situations. The ability to quickly provide accurate test results is essential in hospital settings, particularly in emergency departments where timely diagnostics can significantly impact patient outcomes. Hospitals often implement fully automated systems to streamline laboratory workflows and accommodate the diverse testing needs of various departments, including cardiology, oncology, and infectious diseases. As hospitals continue to invest in advanced technologies to improve patient care and operational efficiency, this segment is expected to maintain a strong growth trajectory in the coming years.

Diagnostic Laboratories:

Diagnostic laboratories play a crucial role in the automated clinical chemistry analyzers market, serving as primary facilities for conducting extensive testing across a wide range of medical conditions. These laboratories require high-throughput analyzers to efficiently manage large volumes of samples and deliver timely results to healthcare providers. The trend towards laboratory consolidation and the increasing demand for accurate diagnostics are driving the growth of this segment. Furthermore, diagnostic laboratories often adopt innovative technologies, such as integrated data management systems, to enhance their service offerings and improve patient management, further contributing to their significance in the automated clinical chemistry analyzers market.

Research Institutes:

Research institutes utilize automated clinical chemistry analyzers to conduct studies and trials that require precise and reliable testing results. These institutions often engage in advanced research areas such as drug development, biomarker discovery, and epidemiological studies, necessitating the use of sophisticated analyzers capable of handling diverse tests. The growing emphasis on research and development in the healthcare sector, especially in the fields of genomics and personalized medicine, is expected to propel the demand for automated analyzers in research institutes. As these institutions continue to seek innovative solutions to enhance their research capabilities, this segment is projected to experience steady growth.

Other:

Other applications of automated clinical chemistry analyzers include veterinary diagnostics, blood banks, and clinical trials. These settings require specialized testing capabilities that can be efficiently addressed by automated systems. As the demand for accurate diagnostics extends beyond human healthcare into veterinary medicine, the market for automated analyzers in these applications is expected to expand. Additionally, the growing focus on research and clinical trials is driving the adoption of analyzers that can provide rapid and reliable test results, thereby enhancing the overall efficiency of the research process. Consequently, this segment is anticipated to witness growth due to the diversification of applications of automated clinical chemistry analyzers.

By Test Type

Basic Metabolic Panel:

The basic metabolic panel (BMP) is a common set of tests used to assess an individual's metabolic status, including electrolyte balance and kidney function. Automated clinical chemistry analyzers facilitate the rapid processing of BMPs, providing healthcare providers with critical information to make informed clinical decisions. The increasing prevalence of metabolic disorders, coupled with the emphasis on preventive healthcare, is driving the demand for BMP testing. As healthcare providers seek to streamline diagnostic processes and enhance patient care, the basic metabolic panel segment is expected to grow within the automated clinical chemistry analyzers market.

Liver Panel:

A liver panel is a series of tests used to evaluate liver function and detect hepatic disorders. The automation of these tests through clinical chemistry analyzers enables quicker results, which are essential in diagnosing liver diseases, including hepatitis and cirrhosis. The rising incidence of liver-related health issues, alongside growing awareness of liver health, is propelling the demand for liver panels. Moreover, advancements in technology are enhancing the accuracy and reliability of liver function tests, making automated analyzers an integral part of liver diagnostics in healthcare settings.

Lipid Profile:

The lipid profile test is crucial for assessing cholesterol levels and the risk of cardiovascular diseases. Automated clinical chemistry analyzers provide efficient and accurate testing capabilities for lipid panels, allowing healthcare professionals to identify patients at risk and initiate appropriate interventions. As the prevalence of cardiovascular diseases continues to rise globally, the demand for lipid profiling is increasing. Furthermore, the automation of these tests enhances laboratory workflow, minimizing manual errors and ensuring timely reporting, which contributes to the growth of the lipid profile test segment in the automated clinical chemistry analyzers market.

Renal Profile:

The renal profile test is vital for evaluating kidney function and detecting renal diseases. Automated clinical chemistry analyzers simplify the process of conducting these tests, providing rapid results that are critical for timely diagnosis and management of kidney-related health issues. The increasing incidence of chronic kidney diseases, linked to rising diabetes and hypertension rates, is driving demand for renal profiling. As healthcare providers prioritize early detection and intervention in renal disorders, the renal profile segment is poised for significant growth within the automated clinical chemistry analyzers market.

Thyroid Function Panel:

The thyroid function panel is an essential diagnostic tool used to assess thyroid gland activity and identify disorders such as hypothyroidism and hyperthyroidism. The automation of these tests through clinical chemistry analyzers allows for consistent and accurate results, which are crucial in diagnosing thyroid-related health conditions. The growing awareness of the impact of thyroid health on overall well-being, coupled with the increasing prevalence of thyroid disorders, is driving the demand for thyroid function testing. As the need for reliable diagnostic solutions continues to escalate, this segment is expected to expand in the automated clinical chemistry analyzers market.

By End User

Hospitals:

Hospitals constitute the largest end-user segment in the automated clinical chemistry analyzers market, primarily due to their demand for high-volume testing and rapid diagnostic capabilities. The ability to provide timely and accurate results in critical care situations is paramount in hospital settings, where decisions regarding patient treatment often rely on laboratory test outcomes. Hospitals frequently invest in advanced automation systems to enhance operational efficiencies, reduce turnaround times, and ensure consistent quality in diagnostics. As the healthcare landscape evolves and the focus on patient-centered care deepens, hospitals are expected to continue leading the market in the adoption of automated clinical chemistry analyzers.

Diagnostic Laboratories:

Diagnostic laboratories are a key end user in the automated clinical chemistry analyzers market, characterized by their need for reliable and efficient testing solutions. These laboratories are essential for conducting a wide variety of tests for patients referred by healthcare providers, necessitating the use of automated systems that can handle high test volumes accurately. The trend toward laboratory consolidation and the increasing demand for comprehensive diagnostic services are propelling growth in this segment. As laboratories strive for operational excellence and enhanced service offerings, the adoption of automated analyzers will continue to expand, reinforcing the significance of diagnostic laboratories in the market.

Research Institutes:

Research institutes play a critical role in advancing medical knowledge and innovation within the healthcare sector. They utilize automated clinical chemistry analyzers to conduct research on diseases, treatment outcomes, and new diagnostic methods. The requirement for precise and reproducible results in research settings drives the demand for advanced automated analyzers that can handle diverse testing protocols. As research initiatives grow, particularly in the fields of genomics and personalized medicine, research institutes are expected to increasingly rely on automated systems to enhance their capabilities and productivity. This will contribute to the growth of the research institutes segment within the automated clinical chemistry analyzers market.

Other:

The "Other" category includes various end users such as veterinary clinics, blood banks, and clinical trial facilities that utilize automated clinical chemistry analyzers for specific testing needs. Each of these sectors requires specialized testing capabilities that can be efficiently managed by automated systems. The demand for veterinary diagnostics is on the rise, driven by increased pet ownership and a growing emphasis on animal health. Similarly, blood banks rely on accurate testing for blood compatibility and infectious disease screening, making automated analyzers essential in these settings. As the focus on precision health extends into diverse applications, the "Other" segment is projected to experience sustained growth in the overall market.

By Region

The North America region dominated the automated clinical chemistry analyzers market, holding a share of over 40% in 2025. The growth in this region can be attributed to the presence of advanced healthcare infrastructure, increasing investment in diagnostics, and high prevalence rates of chronic diseases. Additionally, the strong emphasis on research and development, along with a well-established regulatory framework, supports the adoption of innovative technologies in clinical settings. The market in North America is expected to grow at a CAGR of 6.5% during the forecast period, driven by the continuous advancement of laboratory automation and the demand for rapid testing solutions.

In Europe, the automated clinical chemistry analyzers market is also witnessing notable growth, with a share of approximately 30% in 2025. Factors fueling this growth include the rising incidence of chronic diseases, increased healthcare expenditure, and the growing emphasis on precision medicine. European countries are investing in modernizing laboratory infrastructure and increasing the efficiency of healthcare delivery systems, which further supports the demand for automated analyzers. The Asia Pacific region is anticipated to grow at the highest CAGR of 8.1%, driven by the expanding healthcare infrastructure, increasing awareness of preventive healthcare, and the growing adoption of advanced diagnostic technologies across emerging economies.

Opportunities

The automated clinical chemistry analyzers market presents several opportunities, particularly in emerging economies where healthcare infrastructure is rapidly evolving. As governments and private sectors invest in expanding healthcare facilities, there is a growing demand for advanced diagnostic solutions that can cater to the increasing patient population. The adoption of automated clinical chemistry analyzers in rural and underserved areas is set to enhance access to quality diagnostic services, thus promoting timely interventions and better health outcomes. Moreover, the integration of digital technologies, such as telemedicine and remote monitoring, is opening new avenues for automated testing solutions to reach patients who may otherwise lack access to traditional healthcare facilities.

Another significant opportunity lies in the advancement of technologies such as artificial intelligence and machine learning, which can enhance the capabilities of automated clinical chemistry analyzers. These technologies can facilitate improved data analysis, predictive analytics, and personalized medicine approaches, ultimately leading to more effective diagnostic solutions. Furthermore, the growing emphasis on preventive healthcare and population health management is likely to drive the demand for routine testing and screening programs, thus bolstering the market for automated analyzers. As healthcare providers increasingly prioritize patient-centered care, the automated clinical chemistry analyzers market is positioned to benefit from these evolving trends.

Threats

Despite the promising growth prospects within the automated clinical chemistry analyzers market, several threats could hinder its development. One of the primary concerns is the competitive landscape, where numerous players are continually introducing new products and technologies. This intense competition can lead to price wars, potentially affecting profit margins for manufacturers and impacting their ability to invest in research and development. Furthermore, the rapid pace of technological advancements means that companies must consistently innovate to stay relevant in the market, which could increase operational costs and strain resources.

Another significant threat is the potential for regulatory challenges and compliance issues. Automated clinical chemistry analyzers must adhere to strict regulatory standards, varying by region, which can complicate market entry for new players and extend the time-to-market for innovative products. Changes in government regulations or reimbursement policies could also adversely affect the adoption of automated analyzers in healthcare facilities. Additionally, the risk of cyber threats and data breaches in an increasingly digital healthcare landscape poses another challenge that manufacturers must address to maintain customer trust and safeguard sensitive patient information.

Competitor Outlook

• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthineers
• Beckman Coulter, Inc.
• Thermo Fisher Scientific
• Hitachi High-Technologies Corporation
• Ortho Clinical Diagnostics
• Mindray Medical International Limited
• Sysmex Corporation
• PerkinElmer, Inc.
• Bio-Rad Laboratories, Inc.
• Genzyme Corporation
• Hologic, Inc.
• JASCO Corporation
• DiaSorin S.p.A.

The competitive landscape of the automated clinical chemistry analyzers market is characterized by a mix of established players and emerging companies, each striving to leverage technological advancements to capture market share. Major companies such as Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers lead the market due to their extensive product portfolios, strong distribution networks, and ongoing research and development efforts. These companies continuously invest in enhancing their existing analyzers and expanding their capabilities to meet the changing needs of healthcare providers and laboratories. The presence of numerous regional players also contributes to a diverse competitive environment, promoting innovation and driving overall market growth.

Abbott Laboratories is a key player in the automated clinical chemistry analyzers market, recognized for its extensive range of diagnostic products, including its Alinity series of analyzers, which offer high throughput and versatility. The company focuses on developing innovative solutions that enhance diagnostic accuracy and speed, making it a preferred choice among healthcare facilities. Roche Diagnostics is another leading company, known for its Cobas series of analyzers, which integrate advanced technology for streamlined workflows and improved clinical outcomes. Roche's commitment to research and development allows the company to remain at the forefront of diagnostic innovation, addressing emerging healthcare challenges.

Siemens Healthineers stands out in the market with its wide array of laboratory diagnostics solutions, including fully automated systems that efficiently manage various testing requirements. The company's analyzers are designed to deliver rapid, reliable results while minimizing the need for manual input, thus enhancing overall laboratory efficiency. Similarly, Beckman Coulter, Inc. has established itself as a significant player, offering a comprehensive suite of automated chemistry analyzers that cater to diverse testing needs. The company emphasizes the importance of quality and precision in diagnostics, continually focusing on enhancing its product offerings to meet the evolving demands of the healthcare landscape.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Hologic, Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 DiaSorin S.p.A.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 JASCO Corporation
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 PerkinElmer, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Roche Diagnostics
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Sysmex Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Abbott Laboratories
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Genzyme Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Siemens Healthineers
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Beckman Coulter, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Thermo Fisher Scientific
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Bio-Rad Laboratories, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Ortho Clinical Diagnostics
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Hitachi High-Technologies Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Mindray Medical International Limited
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Automated Clinical Chemistry Analyzers Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Diagnostic Laboratories
    • 6.1.3 Research Institutes
    • 6.1.4 Other
  • 6.2 Automated Clinical Chemistry Analyzers Market, By Test Type
    • 6.2.1 Basic Metabolic Panel
    • 6.2.2 Liver Panel
    • 6.2.3 Lipid Profile
    • 6.2.4 Renal Profile
    • 6.2.5 Thyroid Function Panel
  • 6.3 Automated Clinical Chemistry Analyzers Market, By Application
    • 6.3.1 Hospitals
    • 6.3.2 Diagnostic Laboratories
    • 6.3.3 Research Institutes
    • 6.3.4 Other
  • 6.4 Automated Clinical Chemistry Analyzers Market, By Product Type
    • 6.4.1 Small Benchtop Analyzers
    • 6.4.2 Floor-standing Analyzers
    • 6.4.3 Portable Analyzers
    • 6.4.4 Semi-automated Analyzers
    • 6.4.5 Fully Automated Analyzers

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Automated Clinical Chemistry Analyzers Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Automated Clinical Chemistry Analyzers market is categorized based on

By Product Type

• Small Benchtop Analyzers
• Floor-standing Analyzers
• Portable Analyzers
• Semi-automated Analyzers
• Fully Automated Analyzers

By Application

• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Other

By Test Type

• Basic Metabolic Panel
• Liver Panel
• Lipid Profile
• Renal Profile
• Thyroid Function Panel

By End User

• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Other

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthineers
• Beckman Coulter, Inc.
• Thermo Fisher Scientific
• Hitachi High-Technologies Corporation
• Ortho Clinical Diagnostics
• Mindray Medical International Limited
• Sysmex Corporation
• PerkinElmer, Inc.
• Bio-Rad Laboratories, Inc.
• Genzyme Corporation
• Hologic, Inc.
• JASCO Corporation
• DiaSorin S.p.A.